QuickVue Influenza A+B Test - 25 Test/Kit (20183)

MSRP: $533.33
$359.00
(You save $174.33 )
(No reviews yet) Write a Review
SKU:
PST-QUI-20183
Quidel QuickVue Influenza A+B Test (20183)
  • Intended for the rapid, qualitative detection and differential diagnosis of acute influenza type A and type B viral infections

Overview:

  • Rapid Lateral Flow Immunoassay:

      • Rapid diagnostic test that uses a dipstick format
      • Works by detecting specific antigens (proteins) from the influenza virus

  • CLIA Waived:

    • Means the test is simple to perform and has a low risk of erroneous results
    • Makes it suitable for use in a variety of healthcare settings, including physician's offices, clinics, and other point-of-care locations, often with minimal training

  • Two-Color Endpoint:

    • Results are easy to interpret with two distinct colors appearing on the test strip for positive results and a clear control line

Key features and benefits:

  • Fast Results:

    • Provides results in 10 minutes or less, allowing for quick patient management decisions (e.g., prescribing antivirals)

  • Multiple Sample Types:

    • Can be used with nasal swab, nasopharyngeal swab, nasal wash, or nasal aspirate specimens

  • Easy to Use:

    • Features a simple procedure, often described as having only one step for nasal wash/aspirate samples and three steps for nasal swab samples, with minimal hands-on time (around 30 seconds to 1 minute).

  • Room Temperature Storage: 

    • Kits can be stored at room temperature (15°C to 30°C / 59°F to 86°F) and have a long shelf life (up to 24 months from the date of manufacture), making them convenient for office or lab use

  • Internal Controls:

    • Includes built-in procedural controls to ensure the test is working correctly
    • External controls (positive A, positive B, and negative) are also included in the kit for quality control

  • Aid in Diagnosis:

    • While it provides a rapid result, negative results should ideally be confirmed by cell culture or an FDA-cleared molecular assay, and they should not be the sole basis for treatment decisions
    • Test does not detect influenza C antigens

Contents: 

  • 25 Test Strips (individually pouched)
  • 25 Reagent Tubes (containing lyophilized buffer)
  • 25 Reagent Solution vials
  • 25 Disposable Pipettes
  • 25 Sterile Nasal Swabs (or sometimes nasopharyngeal swabs are sold separately)
  • Positive Influenza Type A Control Swab
  • Positive Influenza Type B Control Swab
  • Negative Control Swab
  • Package Insert (instructions for use)
  • Procedure Card